Suppr超能文献

肝纤维化的分子机制与治疗原则

Molecular mechanisms of hepatic fibrosis and principles of therapy.

作者信息

Friedman S L

机构信息

UCSF School of Medicine 94143, USA.

出版信息

J Gastroenterol. 1997 Jun;32(3):424-30. doi: 10.1007/BF02934504.

Abstract

Tremendous insights into the understanding of hepatic fibrosis have taken place over the past ten years. Foremost among these is the recognition that hepatic stellate cells (formerly known as lipocytes, Ito cells, or fat-storing cells) play a central role based on their ability to undergo activation following liver injury of any cause. Stellate cell activation is a broad phenotypic response, characterized by distinct functional changes in proliferation, contractility, fibrogenesis, cytokine secretion, and matrix degradation. Insights gained into the molecular regulation of hepatic stellate cell activation will lead to new, targeted approaches to hepatic fibrosis in the future, and could lead to reduced morbidity and mortality in patients with chronic liver injury.

摘要

在过去十年中,人们对肝纤维化的认识有了巨大的进展。其中最重要的是认识到肝星状细胞(以前称为脂肪细胞、伊托细胞或贮脂细胞)在任何原因引起的肝损伤后能够被激活,从而发挥核心作用。星状细胞激活是一种广泛的表型反应,其特征是在增殖、收缩性、纤维化形成、细胞因子分泌和基质降解方面有明显的功能变化。对肝星状细胞激活的分子调节的深入了解将在未来带来针对肝纤维化的新的靶向治疗方法,并可能降低慢性肝损伤患者的发病率和死亡率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验